Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
Saved in:
| Title: | Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]. |
|---|---|
| Authors: | Hoffmann K (AUTHOR), Glimm H (AUTHOR), Radeleff B (AUTHOR), Richter G (AUTHOR), Heining C (AUTHOR), Schenkel I (AUTHOR), Zahlten-Hinguranage A (AUTHOR), Schirrmacher P (AUTHOR), Schmidt J (AUTHOR), Büchler MW (AUTHOR), Jaeger D (AUTHOR), von Kalle C (AUTHOR), Schemmer P (AUTHOR), Hoffmann, K1 (AUTHOR), Glimm, H (AUTHOR), Radeleff, B (AUTHOR), Richter, G (AUTHOR), Heining, C (AUTHOR), Schenkel, I (AUTHOR), Zahlten-Hinguranage, A (AUTHOR) |
| Source: | BMC Cancer. 2008, Vol. 8, p349-349. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
